Research Use Only. For Laboratory Research Only. Not for Human or Veterinary Consumption. Not evaluated by the FDA.
Knowledge center

Tesamorelin 10mg

Stabilized GHRH analog

Overview

Overview

Tesamorelin 10mg is a laboratory-grade ghrh analog supplied by BioNEx Peptides for in vitro and preclinical research. Each vial contains 10 mg lyophilized peptide, ≥99% HPLC purity, third-party verified. Intended exclusively for qualified research professionals investigating growth hormones pathways. Not a drug, supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. For research use only — not for human or veterinary consumption.

Background

History

Tesamorelin 10mg has been characterized in the peer-reviewed literature over multiple decades of investigation. This section aggregates published citations spanning its identification, structural characterization, and subsequent laboratory research programs. See the References section below for the full bibliography.

Chemistry

Mechanism of action

Sequence
Molecular Formula
C223H345N45O42S
Molecular Weight
5195.87
CAS Number
218949-48-5
Appearance
Lyophilized white to off-white powder
Purity
≥99% (HPLC)
Literature

Published research

Preclinical

Animal studies

Clinical

Human studies

No human-subject citations catalogued for Tesamorelin 10mg.

Synthesis

Current scientific understanding

Research-grade ghrh analog, ≥99% HPLC purity, lyophilized. Research use only.

References

References

  1. Preclinical peptide research review, Peptides Research Review (2023)
FAQ

Frequently asked questions

Scientific disclaimer

This page aggregates published scientific literature and analytical information for laboratory research reference only. Content is not evaluated by the FDA and does not constitute medical advice, dosage guidance, treatment claims, or administration instructions. Compounds are supplied strictly for in-vitro laboratory research by qualified professionals.